EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program

Brennan Collis iD, Karen Urbancic iD, Jack Whitelaw iD, Gemma Reynolds iD, Sara Vogrin iD, Hossein Jahanabadi iD, Dinesh Pandey iD, Marie Sinclair iD, Avik Majumdar iD, Adam Testro iD, Jason A Trubiano iD, Olivia C Smibert iD

Transplant Infectious Disease · 2025

DOI: 10.1111/tid.70046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Brennan Collis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases & Immunology, Austin Health, Melbourne, Australia. Hauptthemen laut MEDLINE: Antifungal Agents, Liver Transplantation, Antimicrobial Stewardship, Invasive Fungal Infections. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent evidence suggests liver transplant recipients (LiTRs) with invasive aspergillosis (IA) have lower rates of dissemination and mortality compared to historical data. However, contemporary data from other centers remain scarce. We aimed to evaluate modern IA outcomes at our institution, where targeted perioperative echinocandin prophylaxis and an active antifungal stewardship program (AFSP) have been implemented.

Methods

This is a single‐center retrospective analysis of patients who underwent liver transplantation between January 1, 2017 and June 30, 2022. During the study period, targeted anidulafungin perioperative prophylaxis was administered to patients considered high‐risk for invasive fungal infection (IFI), and a multidisciplinary AFSP assisted with IFI diagnosis and management. Patients with proven and probable IA diagnosed post‐operatively were identified using internationally accepted definitions. The primary outcomes were IA dissemination and 1‐year all‐cause mortality rates. Data were extracted from the electronic medical record and descriptive summary statistics were performed.

Results

Six patients (6/377, 1.6%) met the inclusion criteria. Patients with IA were significantly more likely to be colonized with multidrug‐resistant Gram‐negative organisms compared to those without IA (50.0% vs. 12.1%, p = 0.006). The median time to IA diagnosis was 22 days post‐transplant (IQR 5–109). No cases of dissemination were observed. One‐year all‐cause mortality was 16.7%.

Conclusion

Consistent with contemporary data, LiTRs had lower IA dissemination and mortality rates compared to earlier studies. These improved outcomes likely reflect a combination of modern advancements in liver transplantation, and we highlight two potentially modifiable interventions; targeted echinocandin prophylaxis and an AFSP. Further studies are needed to support their broader implementation. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsLiver TransplantationAntimicrobial StewardshipInvasive Fungal InfectionsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTransplant RecipientsAdultAnidulafunginAntibiotic ProphylaxisTreatment Outcome

Stichwörter der Autor:innen

antifungal prophylaxisantimicrobial stewardshipinvasive aspergillosisliver transplantation

Substanzen

Antifungal AgentsAnidulafungin

Autor:innen und Institutionen

  • Department of Infectious Diseases & Immunology, Austin Health, Melbourne, Australia.
  • Department of Pharmacy, Austin Health, Melbourne, Australia.
  • Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • School of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia.
  • Business Intelligence Unit, Austin Health, Melbourne, Australia.

ORCID-Profile: Brennan Collis, Karen Urbancic, Jack Whitelaw, Gemma Reynolds, Sara Vogrin, Hossein Jahanabadi, Dinesh Pandey, Marie Sinclair, Avik Majumdar, Adam Testro, Jason A Trubiano, Olivia C Smibert

Zitieren

APA

Collis, B., Urbancic, K., Whitelaw, J., Reynolds, G., Vogrin, S., Jahanabadi, H., Pandey, D., Sinclair, M., Majumdar, A., Testro, A., Trubiano, J. A., & Smibert, O. C. (2025). Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program. Transplant Infectious Disease. https://doi.org/10.1111/tid.70046

Vancouver

Collis B, Urbancic K, Whitelaw J, Reynolds G, Vogrin S, Jahanabadi H, et al. Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program. Transplant Infectious Disease. 2025. doi:10.1111/tid.70046

BibTeX
@article{Collis2025,
  author = {Collis, Brennan and Urbancic, Karen and Whitelaw, Jack and Reynolds, Gemma and Vogrin, Sara and Jahanabadi, Hossein and Pandey, Dinesh and Sinclair, Marie and Majumdar, Avik and Testro, Adam and Trubiano, Jason A and Smibert, Olivia C},
  title = {Outcomes of Invasive Aspergillosis in Liver Transplant Recipients From an Institution Using Targeted Antifungal Prophylaxis and an Antifungal Stewardship Program},
  journal = {Transplant Infectious Disease},
  year = {2025},
  doi = {10.1111/tid.70046}
}
Kostenlos starten →